Analysis of arsenic metabolites in HepG2 and AS3MT-transfected cells

Archives of Toxicology

Volumn 85, Issue 6, 2011, Pages 577-588

  Watanabe, Takayuki ^a,b   Ohta, Yuki ^b   Mizumura, Ayano ^a   Kobayashi, Yayoi ^a,b   Hirano, Seishiro ^a,b  

^a CHIBA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

Author keywords

Arsenic; AS3MT; Glutathione; ICP MS; Metabolite speciation

Indexed keywords

ARSENIC DERIVATIVE; ARSENIC TRIOXIDE; TETRACYCLINE;

ANIMAL CELL; ARTICLE; AS3MT GENE; BIOACCUMULATION; CELL STRAIN HEPG2; CELL VIABILITY; CHO CELL; CONTROLLED STUDY; CYTOTOXICITY; GENE; HUMAN; HUMAN CELL; METHYLATION; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL;

ANIMALS; ARSENATES; ARSENIC POISONING; ARSENICALS; ARSENITES; CARCINOGENS; CELL SURVIVAL; CELL-FREE SYSTEM; CHO CELLS; CRICETINAE; CRICETULUS; CULTURE MEDIA, CONDITIONED; GLUTATHIONE; HEP G2 CELLS; HEPATOCYTES; HUMANS; METHYLATION; METHYLTRANSFERASES; OXIDATION-REDUCTION; SODIUM COMPOUNDS; SPECIES SPECIFICITY;

EID: 79959616891     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-011-0710-5     Document Type: Article

References (50)

1. Aposhian HV (1997) Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Annu Rev Pharmacol Toxicol 37:397-419
2. Aposhian HV, Aposhian MM (2006) Arsenic toxicology: five questions. Chem Res Toxicol 19:1-15 (Pubitemid 43185456)
3. Aposhian HV, Gurzau ES, Le XC, Gurzau A, Healy SM, Lu X, Ma M, Yip L, Zakharyan RA, Maiorino RM, Dart RC, Tircus MG, Gonzalez-Ramirez D, Morgan DL, Avram D, Aposhian MM (2000) Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic. Chem Res Toxicol 13:693-697 (Pubitemid 30663445)
4. Aposhian HV, Zakharyan RA, Avram MD, Kopplin MJ, Wollenberg ML (2003) Oxidation and detoxification of trivalent arsenic species. Toxicol Appl Pharmacol 193:1-8 (Pubitemid 37373761)
5. Aposhian HV, Zakharyan RA, Avram MD, Sampayo-Reyes A, Wollenberg ML (2004) A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in the detoxication of the trivalent arsenic species. Toxicol Appl Pharmacol 198:327-335 (Pubitemid 38969962)
6. Barchowsky A, Klei LR, Dudek EJ, Swartz HM, James PE (1999) Stimulation of reactive oxygen, but not reactive nitrogen species, in vascular endothelial cells exposed to low levels of arsenite. Free Radic Biol Med 27:1405-1412 (Pubitemid 30001503)
7. Bates MN, Smith AH, Hopenhayn-Rich C (1992) Arsenic ingestion and internal cancers: a review. Am J Epidemiol 135:462-476
8. Buchet JP, Lauwerys R (1985) Study of inorganic arsenic methylation by rat liver in vitro: relevance for the interpretation of observations in man. Arch Toxicol 57:125-129 (Pubitemid 15028765)
9. Buchet JP, Lauwerys R (1987) Study of factors influencing the in vivo methylation of inorganic arsenic in rats. Toxicol Appl Pharmacol 91:65-74
10. Buchet JP, Lauwerys R (1988) Role of thiols in the in vitro methylation of inorganic arsenic by rat liver cytosol. Biochem Pharmacol 37:3149-3153
11. Chen CJ, Chen CW, Wu MM, Kuo TL (1992) Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br J Cancer 66:888-892
12. Chen GQ, Zhu J, Shi XG, Ni JH, Zhong HJ, Si GY, Jin XL, Tang W, Li XS, Xong SM, Shen ZX, Sun GL, Ma J, Zhang P, Zhang TD, Gazin C, Naoe T, Chen SJ, Wang ZY, Chen Z (1996) In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins. Blood 88:1052-1061
13. Conrad ME (1999) Treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med 340:1043-1045
14. Crecelius EA (1977) Changes in the chemical speciation of arsenic following ingestion by man. Environ Health Perspect 19:147-150
15. Del Razo LM, Styblo M, Cullen WR, Thomas DJ (2001) Determination of trivalent methylated arsenicals in biological matrices. Toxicol Appl Pharmacol 174:282-293 (Pubitemid 32747839)
16. Drobna Z, Waters SB, Walton FS, LeCluyse EL, Thomas DJ, Styblo M (2004) Interindividual variation in the metabolism of arsenic in cultured primary human hepatocytes. Toxicol Appl Pharmacol 201:166-177 (Pubitemid 39487164)
17. Drobna Z, Waters SB, Devesa V, Harmon AW, Thomas DJ, Styblo M (2005) Metabolism and toxicity of arsenic in human urothelial cells expressing rat arsenic (?3 oxidation state)-methyltransferase. Toxicol Appl Pharmacol 207:147-159 (Pubitemid 41133501)
18. Drobna Z, Walton FS, Harmon AW, Thomas DJ, Styblo M (2010) Interspecies differences in metabolism of arsenic by cultured primary hepatocytes. Toxicol Appl Pharmacol 245:47-56
19. Gallagher RE (1998) Arsenic-new life for an old potion. N Engl J Med 339:1389-1391
20. Hayakawa T, Kobayashi Y, Cui X, Hirano S (2005) A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19. Arch Toxicol 79:183-191 (Pubitemid 40603183)
21. Hernandez-Zavala A, Matousek T, Drobna Z, Paul DS, Walton F, Adair BM, Jiri D, Thomas DJ, Styblo M (2008) Speciation analysis of arsenic in biological matrices by automated hydride generation-cryotrapping-atomic absorption spectrometry with multiple microflame quartz tube atomizer (multiatomizer). J Anal At Spectrom 23:342-351 (Pubitemid 351312179)
22. Hirano S, Kobayashi Y (2006) Cytotoxic effects of S-(dimethylarsino)- glutathione: a putative intermediate metabolite of inorganic arsenicals. Toxicology 227:45-52 (Pubitemid 44402848)
23. Hirano S, Kobayashi Y, Cui X, Kanno S, Hayakawa T, Shraim A (2004) The accumulation and toxicity of methylated arsenicals in endothelial cells: important roles of thiol compounds. Toxicol Appl Pharmacol 198:458-467 (Pubitemid 38969975)
24. IARC (1987) Overall evaluations of carcinogenicity: an updating of IARC monographs volumes 1 to 42. IARC Monogr Eval Carcinog Risks Hum Suppl 7:1-440
25. IARC (2004) Some drinking-water disinfectants and contaminants, including arsenic. Monographs on chloramine, chloral and chloral hydrate, dichloroacetic acid, trichloroacetic acid and 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)- furanone. IARC Monogr Eval Carcinog Risks Hum 84:269-477
26. Kobayashi Y, Hayakawa T, Hirano S (2007) Expression and activity of arsenic methyltransferase Cyt19 in rat tissues. Environ Toxicol Pharmacol 23:115-120 (Pubitemid 44854655)
27. Le XC, Ma M, Cullen WR, Aposhian HV, Lu X, Zheng B (2000) Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine. Environ Health Perspect 108:1015-1018
28. Lin S, Del Razo LM, Styblo M, Wang C, Cullen WR, Thomas DJ (2001) Arsenicals inhibit thioredoxin reductase in cultured rat hepatocytes. Chem Res Toxicol 14:305-311 (Pubitemid 32238491)
29. Lin S, Shi Q, Nix FB, Styblo M, Beck MA, Herbin-Davis KM, Hall LL, Simeonsson JB, Thomas DJ (2002) A novel S-adenosyl-L-methionine: arsenic(III) methyltransferase from rat liver cytosol. J Biol Chem 277:10795-10803 (Pubitemid 34952833)
30. Lindberg AL, Kumar R, Goessler W, Thirumaran R, Gurzau E, Koppova K, Rudnai P, Leonardi G, Fletcher T, Vahter M (2007) Metabolism of low-dose inorganic arsenic in a central European population: influence of sex and genetic polymorphisms. Environ Health Perspect 115:1081-1086 (Pubitemid 47317076)
31. Liu J, Chen H, Miller DS, Saavedra JE, Keefer LK, Johnson DR, Klaassen CD, Waalkes MP (2001) Overexpression of glutathione S-transferase II and multidrug resistance transport proteins is associated with acquired tolerance to inorganic arsenic. Mol Pharmacol 60:302-309 (Pubitemid 32678295)
32. Look AT (1998) Arsenic and apoptosis in the treatment of acute promyelocytic leukemia. J Natl Cancer Inst 90:86-88
33. Mervis J (1996) Ancient remedy performs new tricks. Science 273:578
34. Mizumura A, Watanabe T, Kobayashi Y, Hirano S (2010) Identification of arsenite-and arsenic diglutathione-binding proteins in human hepatocarcinoma cells. Toxicol Appl Pharmacol 242:119-125
35. Naranmandura H, Suzuki N, Suzuki KT (2006) Trivalent arsenicals are bound to proteins during reductive methylation. Chem Res Toxicol 19:1010-1018 (Pubitemid 44384831)
36. Petrick JS, Jagadish B, Mash EA, Aposhian HV (2001) Monomethylarsonous acid (MMA(III)) and arsenite: LD(50) in hamsters and in vitro inhibition of pyruvate dehydrogenase. Chem Res Toxicol 14:651-656 (Pubitemid 32565713)
37. Sakurai T, Kojima C, Kobayashi Y, Hirano S, Sakurai MH, Waalkes MP, Himeno S (2006) Toxicity of a trivalent organic arsenic compound, dimethylarsinous glutathione in a rat liver cell line (TRL 1215). Br J Pharmacol 149:888-897 (Pubitemid 44851713)
38. Schlawicke Engstrom K, Broberg K, Concha G, Nermell B, Warholm M, Vahter M (2007) Genetic polymorphisms influencing arsenic metabolism: evidence from Argentina. Environ Health Perspect 115:599-605 (Pubitemid 46585533)
39. Shraim A, Cui X, Li S, Ng JC, Wang J, Jin Y, Liu Y, Guo L, Li D, Wang S, Zhang R, Hirano S (2003) Arsenic speciation in the urine and hair of individuals exposed to airborne arsenic through coal-burning in Guizhou, PR China. Toxicol Lett 137:35-48 (Pubitemid 36044039)
40. Slack JL, Rusiniak ME (2000) Current issues in the management of acute promyelocytic leukemia. Ann Hematol 79:227-238 (Pubitemid 30307449)
41. Smith TJ, Crecelius EA, Reading JC (1977) Airborne arsenic exposure and excretion of methylated arsenic compounds. Environ Health Perspect 19:89-93 (Pubitemid 8182680)
42. Smith AH, Hopenhayn-Rich C, Bates MN, Goeden HM, Hertz-Picciotto I, Duggan HM, Wood R, Kosnett MJ, Smith MT (1992) Cancer risks from arsenic in drinking water. Environ Health Perspect 97:259-267
43. Soignet SL, Maslak P, Wang ZG, Jhanwar S, Calleja E, Dardashti LJ, Corso D, DeBlasio A, Gabrilove J, Scheinberg DA, Pandolfi PP, Warrell RP Jr (1998) Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med 339:1341-1348 (Pubitemid 28509343)
44. Styblo M, Thomas DJ (1997) Binding of arsenicals to proteins in an in vitro methylation system. Toxicol Appl Pharmacol 147:1-8 (Pubitemid 27490389)
45. Styblo M, Delnomdedieu M, Thomas DJ (1996) Mono- and dimethylation of arsenic in rat liver cytosol in vitro. Chem Biol Interact 99:147-164 (Pubitemid 26042958)
46. Styblo M, Del Razo LM, LeCluyse EL, Hamilton GA, Wang C, Cullen WR, Thomas DJ (1999) Metabolism of arsenic in primary cultures of human and rat hepatocytes. Chem Res Toxicol 12:560-565 (Pubitemid 29354737)
47. Styblo M, Del Razo LM, Vega L, Germolec DR, LeCluyse EL, Hamilton GA, Reed W, Wang C, Cullen WR, Thomas DJ (2000) Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch Toxicol 74:289-299 (Pubitemid 30660931)
48. Waters SB, Devesa V, Del Razo LM, Styblo M, Thomas DJ (2004a) Endogenous reductants support the catalytic function of recombinant rat cyt19, an arsenic methyltransferase. Chem Res Toxicol 17:404-409 (Pubitemid 38375065)
49. Waters SB, Devesa V, Fricke MW, Creed JT, Styblo M, Thomas DJ (2004b) Glutathione modulates recombinant rat arsenic (+3 oxidation state) methyltransferase-catalyzed formation of trimethylarsine oxide and trimethylarsine. Chem Res Toxicol 17:1621-1629 (Pubitemid 39665554)
50. Wildfang E, Radabaugh TR, Vasken Aposhian H (2001) Enzymatic methylation of arsenic compounds. IX. Liver arsenite methyltransferase and arsenate reductase activities in primates. Toxicology 168:213-221